Implications of commercializing COVID-19 vaccines, treatments
The U.S. government could stop paying for COVID-19 vaccines and treatments, which would shift the burden to the commercial market. Dr. Céline Gounder, a CBS News contributor and editor at large for Kaiser Health News, discussed the impact of potentially commercializing coronavirus vaccines and treatments.
